Isotope-Labeled Compounds
Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time.
MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.
All Product Categories
-
Isotope-Labeled Compounds Related Products (11046)
Related Products (11046)
-
3,4,4',5-Tetrachloro-1,1'-biphenyl-13C12
0 ImagesCat. No.: HY-W748290CAS No.: 208461-24-9Synonyms: 3,4,4',5-Tetrachlorobiphenyl-13C123,4,4',5-Tetrachloro-1,1'-biphenyl-13C12 is 13C labeled 3,4,4',5-Tetrachloro-1,1'-biphenyl.
-
Fenofibric acid-d4
0 ImagesCat. No.: HY-B0760S2Synonyms: FNF acid-d4Fenofibric acid-d4 (FNF acid-d4) is deuterium labeled Fenofibric acid. Fenofibric acid, an active metabolite of fenofibrate, is a PPAR activitor, with EC50s of 22.4 μM, 1.47 μM, and 1.06 μM for PPARα, PPARγ and PPARδ, respectively; Fenofibric acid also inhibits COX-2 enzyme activity, with an IC50 of 48 nM.
-
2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)-13C2,15N2
0 ImagesCat. No.: HY-165694S2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)-13C2,15N2 is 13C and 15N labeled 2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium).
-
Norethindrone-d8
0 ImagesCat. No.: HY-B0554S2Synonyms: Norethisterone-d8Norethindrone-d8 (Norethisterone-d8) is deuterium labeled Norethindrone. Norethindrone is a female progestin approved by FDA for the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea.
-
Dabigatran-d5 hydrochloride
0 ImagesCat. No.: HY-10163AS1Dabigatran-d5 (hydrochloride) is the deuterium labeled Dabigatran hydrochloride.
-
Isoprothiolane-d4
0 ImagesCat. No.: HY-B1858SCAS No.: 1715020-82-8Isoprothiolane-d4 is the deuterium labeled Isoprothiolane (HY-B1858). Isoprothiolane is a blast fungicide with antifungal, anti-inflammatory and insecticidal activities. Isoprothiolane primarily acts on fungi during the penetration and growth stages of infecting hyphae. Isoprothiolane can be used as an insecticide, pesticide, etc. In addition, Isoprothiolane can reduce serum phospholipid and total lipid concentrations, regulating lipid metabolism. Isoprothiolane is also used in the research of fatty liver.
-
EPA method 533 isotope dilution standard 0.5-2 mg/mL in methanol:water
0 ImagesCat. No.: HY-181844MSEPA Method 533 Isotope Dilution Standard 0.5-2 μg/mL in Methanol:Water is a mixed standard of isotope internal standards.
-
4-Pregnen-11β,21-diol-3,20-dione-d8
0 ImagesCat. No.: HY-154743S4-Pregnen-11β,21-diol-3,20-dione-d8 is deuterated labeled 4-Pregnen-11β,21-diol-3,20-dione.
-
2-Bromobenzoic acid-d4
0 ImagesSynonyms: O-Bromobenzoic acid-d42-Bromobenzoic acid-d4 is the deuterium labeled 2-Bromobenzoic acid.
-
2-Hydroxyestradiol-d5
0 ImagesCat. No.: HY-124489S1CAS No.: 221093-33-02-Hydroxyestradiol-d5 is the deuterium labeled 2-Hydroxyestradiol. 2-Hydroxyestradiol, a metabolite of 17β-estradiol with minimal estrogenic activity, possesses antioxidant effects and reacts with DNA to form stable adducts and exerts genotoxicity[.
-
6-Heptyltetrahydro-2H-pyran-2-one-d7
0 ImagesCat. No.: HY-W009815S2CAS No.: 3028868-79-0Synonyms: δ-Laurolactone-d76-Heptyltetrahydro-2H-pyran-2-one-d7 is deuterated labeled 6-Heptyltetrahydro-2H-pyran-2-one.
-
Pinaverium bromide-d4-1
0 ImagesCat. No.: HY-111613S1
-
l-Gatifloxacin-d4
0 ImagesCat. No.: HY-154777Sl-Gatifloxacin-d4 is deuterated labeled l-Gatifloxacin.
-
Chlorothalonil Metabolite R611553-13C2,15N2(sodium salt)
0 ImagesCat. No.: HY-165691SChlorothalonil Metabolite R611553-13C2,15N2 (sodium salt) is 13C and 15N labeled Chlorothalonil Metabolite R611553 (sodium salt).
-
Fmoc-Ser(tBu)-OH-13C3,15N
0 ImagesFmoc-Ser(tBu)-OH-13C3,15N is a 15N-labeled and 13C-labled Fmoc-Ser(tBu)-OH (HY-W007941). Fmoc-Ser(tBu)-OH is a serine derivative.
-
Dodecanedioic acid-d4
0 ImagesDodecanedioic acid-d4 is the deuterium labeled Dodecanedioic acid (HY-W012241). Dodecanedioic acid is an orally active straight-chain dicarboxylic acid. As an alternative energy substrate between lipids and carbohydrates, Dodecanedioic acid can be rapidly oxidized during exercise, reducing muscle fatigue without stimulating insulin secretion. Dodecanedioic acid also exhibits blood glucose-lowering activity in non-insulin-dependent diabetes mellitus.
-
N,N-Dimethyl-2-sulfamoylnicotinamide-d6
0 ImagesCat. No.: HY-W071201SSynonyms: 2-Aminosulfonyl-N,N-dimethylnicotinamide-d6N,N-Dimethyl-2-sulfamoylnicotinamide-d6 (2-Aminosulfonyl-N,N-dimethylnicotinamide-d6) is deuterium labeled N,N-Dimethyl-2-sulfamoylnicotinamide.
-
Simvastatin acid-d3 ammonium
0 ImagesCat. No.: HY-119695AS2Synonyms: Tenivastatin-d3 ammoniumSimvastatin acid-d3 (Tenivastatin-d3) ammonium is deuterium-labeled Simvastatin acid (ammonium) (HY-119695A).
-
Fenspiride-d5 hydrochloride
0 ImagesCat. No.: HY-A0027SCAS No.: 1246815-28-0Fenspiride-d5 hydrochloride is the deuterium labeled Fenspiride hydrochloride (HY-A0027). Fenspiride hydrochloride is an α adrenergic and H1 histamine receptor antagonist.
-
Difelikefalin-d5
0 ImagesCat. No.: HY-17609SSynonyms: CR-845-d5; FE-202845-d5Difelikefalin-d5 (CR-845-d5; FE-202845-d5) is the deuterated-labeled Difelikefalin (HY-17609). Difelikefalin (CR-845; FE-202845) is an orally active peripherally acting kappa opioid receptor agonist. Difelikefalin reduces acute kidney injury, decreases oliguria, maintains urine flow, inhibits cytokine expression, and improves survival in endotoxemia after ischemia/reperfusion. Difelikefalin suppresses pruritus signals and exhibits neuromodulatory antipruritic activity. Difelikefalin can be used in research related to acute kidney injury, chronic kidney disease-associated pruritus, and atopic dermatitis.
